Asacol HD: Package Insert - Drugs.com
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Mesalamine | C7H7NO3 - PubChem
Asacol (Mesalamine Delayed-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Asacol®(mesalamine)Delayed-Release Tablets
Asacol: Package Insert / Prescribing Information - Drugs.com
A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug | SpringerLink
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Inflammatory Bowel Disease: Front-line Issues in Diagnosis & Management (Transcript)
Concentration Dependence of 5-Aminosalicylic Acid Pharmacological Actions in Intestinal Mucosa after Oral Administration of a pH-Dependent Formulation | Molecular Pharmaceutics
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis | British Journal of Hospital Medicine
Mesalazine - Wikipedia
Which 5-ASA? Understanding the choices in ulcerative colitis therapy | Gastrointestinal Nursing
Pentasa (Asacol, Mesalamine, Mesalazine) - Uses, Dose, Side effects
Reference ID: 3927159
Solved 3. What is t he mechanism of action of the mesalamine | Chegg.com
Review article: 5‐aminosalicylate formulations for the treatment of ulcerative colitis – methods of comparing release rates and delivery of 5‐aminosalicylate to the colonic mucosa - LICHTENSTEIN - 2008 - Alimentary Pharmacology & Therapeutics ...
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Pharmacokinetics: efficacy and safety of MMX mesalamine formulation for treating ulcerative colitis
Market share and revenue reached by Shire's products Lialda ® and... | Download Table
Asacol®(mesalamine)Delayed-Release Tablets
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Reference ID: 3927159
